| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |